Back

Non-lipid metabolomic biomarkers are associated with adverse cardiac remodelling and cardiovascular outcomes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Non-classical risk factors for heart disease revisited Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mihir Sanghvi

Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Interplay between family History and polygenic risk for coronary heart disease: a cohort study among over 60 thousand individuals
Doctor C. Iribarren (Oakland, US)
Abstract Slides Video
Presentation thumbnail
Association of Life's Essential 8 metrics with mortality outcomes in US cancer survivors
Doctor W. Chen (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
AI-enhanced detection of coronary inflammation predicts 10-year risk for cardiac mortality and MACE in individuals with no or minimal coronary atherosclerosis on routine CCTA
Doctor K. Chan (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol and mortality in 37.559 patients from LIPIDOGRAM 2004, 2006 and 2015 studies.
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Identifying clinical phenotype clusters for coronary artery disease: a novel approach using clustering by unsupervised machine learning
Mr J. Holtrop (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Non-classical risk factors for heart disease revisited
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources